Enovis Corp
ENOV
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.25B
Close$
$-12.76
158.5% downside
Current Fair Value
158.5% downsideOvervalued by 158.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.25 Billion |
|---|---|
| Enterprise Value | $1.32 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-20.86 |
| Beta | 1.49 |
| Outstanding Shares | 56,792,000 |
Return
| Return on Equity | -82.10% |
|---|---|
| Return on Assets | -31.64% |
| Return on Invested Capital | -36.75% |
Valuation & Multiples
| P/E Ratio | -1.09 |
|---|---|
| PEG | 1.29 |
| Price to Sales | 0.7 |
| Price to Book Ratio | 0.84 |
| Enterprise Value to Revenue | 0.73 |
| Enterprise Value to EBIT | -1.11 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$0.82
Average shareholder expectationRevenue Estimate
$573.09 M
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$0.83
Average shareholder expectationRevenue Estimate
$583.20 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0251▲ 0.16% |
|---|---|
| Total Calls | 2,773,380▲ 23.02% |
| Total Puts | 69,700▲ 31.51% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 118.11%▲ 2.18% |
|---|---|
| Total Invested | $1.53B▼ 13.04% |
| Investors Holding | 261▼ 4.00% |
ESG Score
No data
About Enovis Corp
15,400 employees
CEO: Matthew Trerotola Colfax Corporation is a leading diversified technology company that provides specialty medical technologies and fabrication technology products and services to customers around the world, principally under the DJO and ESAB brands. Colfax...